Anika to Participate in the 2019 Morgan Stanley Global Healthcare Conference on September 10, 2019
September 03 2019 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
orthopedic and regenerative medicines company specializing in
therapeutics based on its proprietary hyaluronic acid ("HA")
technology, today announced that Joseph Darling, President and
Chief Executive Officer, and Sylvia Cheung, Chief Financial
Officer, will participate in a fireside chat at the 2019 Morgan
Stanley Global Healthcare Conference on Tuesday, September 10, 2019
at 8:35 am ET. The conference is being held at the Grand Hyatt
Hotel in New York, NY.
A live audio webcast of the session may be accessed via the
“Investor Relations” section of Anika’s website at
www.anikatherapeutics.com. An audio archive of the session will
also be available on the website.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated
orthopedic and regenerative medicines company based in Bedford,
Massachusetts. Anika is committed to improving the lives of
patients with degenerative orthopedic diseases and traumatic
conditions with clinically meaningful therapies along the continuum
of care, from palliative pain management to regenerative tissue
repair. The Company has over two decades of global expertise
developing, manufacturing, and commercializing more than 20
products based on its proprietary hyaluronic acid (HA) technology.
Anika's orthopedic medicine portfolio includes ORTHOVISC®,
MONOVISC®, and CINGAL®, viscosupplements which alleviate pain and
restore joint function by replenishing depleted HA, and HYALOFAST,
a solid HA-based scaffold to aid cartilage repair and regeneration.
For more information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190903005775/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer or For Media Inquiries: Pure
Communications, Inc. Sonal Vasudev, 917-523-1418
sonal@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024